Japan · Legal status and models

Open blank reference book on a dark desk in a quiet legal research library.

Surrogacy in Japan: Legal Status, Prohibitions and Paid vs Unpaid Arrangements

Short answer

Japan does not have a comprehensive statutory framework that clearly authorizes and regulates surrogacy from matching through parentage, payment and registration. In the official sources as of 24 October 2026, no enacted statute was located that expressly prohibits every surrogacy arrangement as such. That limited finding must not be turned into the conclusion that surrogacy is simply “legal”, that a contract will be enforceable, or that a clinic can lawfully provide every requested service.

The most important established rule concerns legal motherhood. Article 9 of Act No. 76 of 2020 provides that, where a woman conceives and gives birth through assisted reproductive technology using another woman’s egg or an embryo derived from it, the woman who gives birth is the child’s mother. The Supreme Court had already applied a birth-based approach in its decision of 23 March 2007 and refused, on the facts before it, to recognize a foreign judgment naming the intended parents as the child’s parents.

Japan’s professional medical guidance, contractual uncertainty and cross-border parentage issues therefore matter even where no surrogacy-specific statutory offence has been identified. Paid and unpaid arrangements are not interchangeable legal safe harbours. The practical answer depends on the proposed procedure, the carrier’s role, genetic relationships, the parties’ status, the contract, the provider and every country involved.

Does Japanese law expressly ban surrogacy?

The legal position is best described as not comprehensively regulated, with major legal and professional constraints, rather than as a simple yes-or-no rule. The Supreme Court’s 2007 decision did not authorize surrogacy generally: it refused recognition of the foreign parentage judgment in the case before it. The Assisted Reproductive Technology Parentage Act enacted in 2020 did not create a complete licensing or authorization scheme for surrogacy. In the official sources, no later comprehensive surrogacy statute was located as in force by 24 October 2026; this is a qualified current-source finding, not a statement that every arrangement is permitted.

This does not establish general legal permission. A rule that does not expressly prohibit a contract does not prove that the contract is valid, that a court would enforce every term, that a medical provider may perform the procedure, or that the intended parents will be registered as legal parents. General civil-law principles, public policy, medical-professional rules, family-registration rules and the laws of the place of treatment or birth may still affect the outcome.

It is also necessary to distinguish different questions. The lawfulness of a medical procedure, the enforceability of an agreement, legal maternity, legal paternity, recognition of a foreign judgment, nationality and travel documents are separate issues. A positive answer to one does not settle the others. Any conclusion should identify the exact act, person, jurisdiction and legal consequence being assessed.

The statutory rule on legal motherhood

Article 9 of the Act on the Provision of Assisted Reproductive Technology and the Parent-Child Relationship of Children Born as a Result of Such Technology (Act No. 76 of 2020) states that when a woman conceives and gives birth through assisted reproductive technology using another woman’s egg, including an embryo derived from that egg, the woman who gives birth is the child’s mother. The parentage provisions in Chapter III took effect on 11 December 2021 and apply to children born through assisted reproductive technology on or after that date.

For a gestational-surrogacy arrangement using the intended mother’s egg or a donor’s egg, the statutory wording is directly relevant: genetic connection to the intended mother does not by itself make her the legal mother under this rule. The same caution applies where an embryo created from another woman’s egg is transferred to the carrier. The rule concerns legal parentage, not whether the intended mother is genetically related to the child, whether the parties consented, or whether a foreign clinic regards the intended parents as parents.

Where the carrier uses her own egg (sometimes called traditional or genetic surrogacy), the wording of Article 9 is not identical to that fact pattern because it expressly refers to another woman’s egg. That distinction should not be mistaken for a route to automatic recognition of the intended mother. The established birth-based approach in Japanese case law makes the legal position high-risk, and the exact route must be checked by Japanese counsel. Article 9 does not provide a comprehensive procedure for transferring parentage from a carrier to intended parents.

What did the Supreme Court decide?

On 23 March 2007, the Supreme Court of Japan decided case 2006 (Kyo) 47. A Japanese married couple had used assisted reproductive technology abroad with the intended mother’s egg and the intended father’s sperm; a woman in Nevada carried and delivered the twins. A Nevada court issued a judgment identifying the intended couple as the children’s legal parents. Japanese authorities refused the couple’s birth notifications, and the dispute reached the Supreme Court.

The Supreme Court held that, under Japanese law, the woman who conceived and delivered the child was the mother, even though another woman had supplied the egg. It also refused to recognize the foreign judgment in that case because recognition would conflict with Japanese public policy under the foreign-judgment recognition rules discussed in Article 118(iii) of the Code of Civil Procedure. The ruling is an important warning that an order or birth certificate issued abroad does not automatically determine parentage in Japan.

The decision should be stated precisely. It was made on particular facts and addressed a particular foreign judgment; it is not a substitute for examining every later judgment, country or procedural route. Article 9 of the 2020 Act now expressly addresses the mother where ART uses another woman’s egg or an embryo derived from it. A Japanese lawyer should assess the current statutory rule together with the foreign decision, the genetic and gestational facts, the applicable conflict-of-laws rules and the procedure sought in Japan.

Commercial and altruistic arrangements

Neither a paid (“commercial”) nor an unpaid (“altruistic”) arrangement should be presented as automatically authorized in Japan. The sources do not establish a general rule that every payment makes a surrogacy arrangement criminal, but they also do not establish that a paid contract is enforceable or that an unpaid arrangement avoids parentage and medical-policy barriers. Payment, expense reimbursement, compensation for time or risk, agency fees and payment for a child are legally different concepts and should not be collapsed into one label.

The 2025 bill is discussed separately below; it did not become law in that Diet session, and its proposed provisions are not binding current law.

QuestionPaid arrangementUnpaid arrangementLegal takeaway
Does the label establish legality?No. Payment does not itself prove that the whole arrangement is lawful or unlawful.No. Absence of payment is not statutory authorization.Assess the actual conduct and applicable laws.
Does it solve parentage?No. Payment cannot displace the Japanese birth-based motherhood rule.No. Altruism does not make the intended mother the legal mother automatically.Parentage needs separate legal analysis.
Does it guarantee clinical access?No. Professional guidance and provider policy still matter.No. The same professional and practical barriers may apply.Obtain current written confirmation from the actual provider.

Medical-professional rules are different from legislation

The Japan Society of Obstetrics and Gynecology (JSOG) has longstanding professional views on surrogate gestation that oppose its use by Society members. The Society’s own discussion materials distinguish such professional self-regulation from national legislation and describe its reach as limited by the membership framework. This guidance is important in practice, but it is not itself a statute enacted by the Diet and should not be described as a criminal ban binding every doctor, clinic or agency in Japan.

The practical consequences depend on the clinician, the facility, membership and the current wording of the relevant professional guidance. A clinic may decline to provide a service even where no specific criminal offence has been identified; conversely, an advertisement or an informal assurance is not proof that a service is permitted or that the resulting parentage will be accepted. The sources do not establish a uniform policy for every provider, so this article makes no claim about the availability of a named clinic.

Before relying on a Japanese provider, obtain written confirmation of the exact procedure offered, the professional rules it considers applicable, the identity and professional status of the clinician, and the facility’s position on gestational or traditional surrogacy. Treat clinic policy as operational practice, not as a substitute for statutory analysis or a guarantee of legal parentage.

The 2025 bill: proposed restrictions, not binding law

A Special Assisted Reproductive Medicine Bill was introduced in the House of Councillors on 5 February 2025. Proposed Article 66 would have prohibited giving or receiving, offering, demanding or promising financial benefits in return for providing sperm, eggs or embryos or for surrogate gestation. Proposed Article 67 separately addressed paid brokerage of providing or receiving sperm, eggs or embryos and, in paragraph 2, paid brokerage of surrogate gestation or a request for it. It therefore expressly covered remunerated surrogacy brokerage; it did not make every unpaid agency activity a prohibited paid-brokerage offence. These provisions were proposals only: a bill does not become law merely because it has been introduced or its text is available online.

The official Diet record lists the proposal as not completed and shows no promulgation date or law number. In a statement dated 28 June 2025, JSOG reported that the bill had not been considered during the ordinary Diet session and was expected to lapse when that session closed on 22 June 2025. We have not found an enacted replacement in the current official Diet bill list.

These proposed provisions are legislative history only, not binding current law. The fact that the bill did not become law does not establish that any paid arrangement is valid, enforceable, medically available or free of other legal consequences. The present position remains fragmented: statutory parentage rules, court interpretation, professional guidance and facts in each country involved must be assessed separately.

What remains unresolved?

Several important questions are not answered simply by observing that no comprehensive surrogacy statute was located. First, the legal effect of a particular contract depends on its wording, governing law, public-policy considerations and the remedies sought. A contract cannot safely promise that a court will compel a carrier to undergo a procedure, continue a pregnancy, terminate a pregnancy or surrender a child. Medical consent, bodily autonomy and the child’s welfare require independent attention; a private agreement is not a substitute for legal and clinical safeguards.

Second, legal maternity and legal paternity must be analysed separately. Article 9 addresses maternity in the specified donor-egg or donor-embryo scenario. It does not create a general surrogacy parentage order, and it does not settle every issue concerning the intended father. Genetics, marriage, consent, the carrier’s status, the location of treatment and birth, and the wording and recognition of a foreign judgment may all matter. A foreign birth certificate, DNA test or court order should not be treated as an automatic answer for Japanese family registration.

Third, nationality, passport issuance, consular registration, permission to travel and the child’s status in the birth country are separate from Japanese parentage. A child may be recognized differently by different legal systems. This article does not determine citizenship for any child or explain the complete birth-registration procedure. These are fact-specific issues that should be resolved before treatment, not after birth when travel or registration deadlines may be running.

Finally, professional guidance and clinic availability can change. The absence of a specific nationwide surrogacy statute does not mean that all medical providers accept the procedure or that a particular arrangement can be carried out safely or lawfully. Do not infer permission from silence, a clinic’s marketing, another family’s experience or the fact that an arrangement is unpaid.

Practical checklist before taking any step

Before signing an agreement, paying an intermediary or beginning treatment, ask Japanese counsel to review the actual plan in writing. At minimum, work through the following items:

  1. Define the model and every country. Identify whether the arrangement is gestational or traditional, whose egg and sperm will be used, where treatment and birth will occur, where the parties live, and which laws govern the contract.
  2. Confirm current law. Re-check Act No. 76 of 2020, Article 9, the relevant case law and official legislative records. Ask counsel to confirm whether any later bill or enactment has changed the position after the sources.
  3. Verify the provider. Obtain the clinic’s written position on the exact procedure, the clinician’s professional status and any current JSOG guidance or facility rules. Do not rely solely on a broker’s statement that a programme is “legal in Japan”.
  4. Review payments and contract terms. Separate compensation, reimbursements, agency fees and medical costs. Review governing law, dispute resolution, insurance, confidentiality, records, withdrawal, pregnancy decisions and what happens if a transfer fails, the carrier changes her mind, multiple births occur or intended parents separate or die.
  5. Map parentage and registration. Obtain a separate opinion on the legal mother and father, recognition of any foreign judgment, family-register entries, documents required at birth and the procedure if the first registration is refused.
  6. Map nationality and travel. Confirm in advance which nationality rules may apply, whether a passport or emergency travel document can be issued, and what each relevant consulate and border authority will require. Do not assume genetic connection alone settles citizenship.
  7. Protect all participants and the child. Ensure independent advice and informed consent, clear medical decision-making, appropriate insurance and care, preservation of records, and a plan that prioritizes the child’s welfare if the adults disagree.

These steps do not guarantee approval or enforceability. They are designed to expose legal dependencies before an irreversible medical or financial step is taken.

Conclusion and scope limits

The most defensible summary is that Japan has a significant gap between parentage rules and a comprehensive surrogacy-specific regulatory system. The absence of a located express statutory ban is not a reliable basis for calling surrogacy lawful, while Article 9 of Act No. 76 of 2020 and the Supreme Court’s 2007 decision make the intended mother’s legal status a central risk. Neither payment nor altruism resolves that risk.

It is not an opinion on any individual’s eligibility, contract, clinic, foreign birth or nationality.

Official sources

The proposed 2025 bill is cited as legislative history only, not as enacted law. The official Ministry of Justice overview was also checked; the statutory text remains the controlling source for Article 9.

Guides for Japan

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards